We're sorry, but BRENDA doesn't work properly without JavaScript. Please make sure you have JavaScript enabled in your browser settings.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
IUBMB Comments A group of enzymes of varying specificity hydrolysing beta-lactams; some act more rapidly on penicillins, some more rapidly on cephalosporins. The latter were formerly listed as EC 3.5.2.8, cephalosporinase.
The taxonomic range for the selected organisms is: Bacillus licheniformis The enzyme appears in selected viruses and cellular organisms
Synonyms
beta-lactamase, carbapenemase, extended-spectrum beta-lactamase, ndm-1, penicillinase, tem-1, blandm-1, ges-1, blactx-m-15, kpc-2,
more
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
exo-small beta-lactamase
-
Beta lactamase OXA-10
-
-
-
-
beta-lactamase AME I
-
-
-
-
beta-lactamase II
-
-
-
-
Imipenem-cefoxitin hydrolyzing enzyme
-
-
-
-
metallo-beta-lactamase
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
a beta-lactam + H2O = a substituted beta-amino acid
Glu166 is important for catalysis, mechanism
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
carboxylic acid amide hydrolysis
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
beta-lactam hydrolase
A group of enzymes of varying specificity hydrolysing beta-lactams; some act more rapidly on penicillins, some more rapidly on cephalosporins. The latter were formerly listed as EC 3.5.2.8, cephalosporinase.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
7-beta-formamidoyl-7-alpha-methoxycephalosporanic acid + H2O
(2R)-5-[(acetyloxy)methyl]-2-{(S)-carboxy[(E)-(hydroxymethylidene)amino]methoxymethyl}-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
-
-
-
?
a penicillin + H2O
a penicilloic acid
-
-
-
?
cefoxitin + H2O
(2R)-5-[(carbamoyloxy)methyl]-2-[(S)-carboxy(methoxy)[(thiophen-2-ylacetyl)amino]methyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
-
-
-
?
cefuroxime + H2O
(2R)-5-[(carbamoyloxy)methyl]-2-[(R)-carboxy{[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetyl]amino}methyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
-
-
-
?
cephalotin + H2O
(2R)-5-[(acetyloxy)methyl]-2-[(R)-carboxy[(thiophen-2-ylacetyl)amino]methyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
-
-
-
?
moxalactam + H2O
(2R)-2-{(R)-carboxy[2-carboxy(4-hydroxyphenyl)acetamido]methoxymethyl}-5-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,6-dihydro-2H-1,3-oxazine-4-carboxylic acid
-
-
-
?
penicillin G + H2O
(2R,4S)-2-[(R)-carboxy[(phenylacetyl)amino]methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
-
-
-
?
6-aminopenicillanic acid + H2O
(2R,4S)-2-[amino(carboxy)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
-
-
-
-
?
7-(thienyl-2-acetamido)-3-[2-(4-N,N-dimethylaminophenylazo)pyridinium-methyl]-3-cephem-4-carboxylic acid + H2O
(2R)-2-[(R)-carboxy{(E)-[1-hydroxy-2-(thiophen-2-yl)ethylidene]amino}methyl]-5-{[(2E)-2-{[4-(dimethyliminio)cyclohexa-2,5-dien-1-ylidene]hydrazinylidene}pyridin-1(2H)-yl]methyl}-3,6-dihydro-2H-1,3-thiazine-4-carboxylate
-
i.e. PADAC
-
-
?
ampicillin + H2O
(2R,4S)-2-[(R)-[[(2R)-2-amino-2-phenylacetyl]amino](carboxy)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
-
-
-
-
?
benzyl cephalosporin C + H2O
(2R)-5-[(acetyloxy)methyl]-2-[(R)-{[(5R)-5-amino-6-(benzyloxy)-6-oxohexanoyl]amino}(carboxy)methyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
-
-
-
-
?
benzylpenicillin + H2O
(2R,4S)-2-[(R)-carboxy(2-phenylacetamido)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
-
-
-
-
?
cephalosporin C + H2O
N6-[(R)-{(2R)-5-[(acetyloxy)methyl]-4-carboxy-3,6-dihydro-2H-1,3-thiazin-2-yl}(carboxy)methyl]-6-oxo-D-lysine
-
-
-
-
?
methicillin + H2O
(2R,4S)-2-[(R)-carboxy(2,6-dimethoxybenzamido)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
nitrocefin + H2O
(2R)-2-{(R)-carboxy[2-(thiophen-2-yl)acetamido]methyl}-5-[(E)-2-(2,4-dinitrophenyl)ethenyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid
-
-
-
-
?
phenoxymethylpenicillin + H2O
(2R,4S)-2-[(R)-carboxy(2-phenoxyacetamido)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
-
-
-
-
?
methicillin + H2O
(2R,4S)-2-[(R)-carboxy(2,6-dimethoxybenzamido)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
-
-
-
-
?
methicillin + H2O
(2R,4S)-2-[(R)-carboxy(2,6-dimethoxybenzamido)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
-
-
-
-
ir
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
cefoxitin
perturbs the active site structure and the conformation of the omega-loop bearing the catalytic residue Glu166, inhibition mechanism
lactivicin
inhibits penicillin-binding proteins and serine beta-lactamases
phenoxyacetyllactivicin
-
additional information
inhibition kinetics
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.085
cefuroxime
wild-type, pH 7.0, 22°C
0.0079 - 0.072
penicillin G
0.0166
6-aminopenicillanic acid
-
both strains
0.14
7-(thienyl-2-acetamido)-3-[2-(4-,N,N-dimethylaminophenylazo)pyridinium-methyl]-3-cephem-4-carboxylic acid
-
wild type
0.21
ampicillin
-
wild type
0.05
benzylcephalosporin C
-
both strains
0.009 - 0.12
benzylpenicillin
0.05
cephalosporin C
-
strain 749/C
0.00023 - 0.00093
Methicillin
0.041
nitrocefin
-
wild type
0.1
phenoxymethylpenicillin
-
wild type
additional information
additional information
kinetics
-
0.0079
penicillin G
mutant E166C, carrying 6-bromoacetyl-2-dimethylaminonaphthalene label, pH 7.0, 22°C
0.048
penicillin G
wild-type, pH 7.0, 22°C
0.072
penicillin G
mutant E166C, pH 7.0, 22°C
0.009
benzylpenicillin
-
strain 6346/C
0.049
benzylpenicillin
-
strain 749/C
0.12
benzylpenicillin
-
wild type
0.00023
Methicillin
-
strain 6346/C
0.00093
Methicillin
-
strain 749/C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.02
cefuroxime
wild-type, pH 7.0, 22°C
667
7-(thienyl-2-acetamido)-3-[2-(4-,N,N-dimethylaminophenylazo)pyridinium-methyl]-3-cephem-4-carboxylic acid
-
-
2650
benzylpenicillin
-
-
2550
phenoxymethylpenicillin
-
-
0.32
penicillin G
mutant E166C, carrying 6-bromoacetyl-2-dimethylaminonaphthalene label, pH 7.0, 22°C
2.1
penicillin G
mutant E166C, pH 7.0, 22°C
2612
penicillin G
wild-type, pH 7.0, 22°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.2
cefuroxime
wild-type, pH 7.0, 22°C
29
penicillin G
mutant E166C, pH 7.0, 22°C
40
penicillin G
mutant E166C, carrying 6-bromoacetyl-2-dimethylaminonaphthalene label, pH 7.0, 22°C
54000
penicillin G
wild-type, pH 7.0, 22°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
5417
-
strain 749/C, exoenzyme
900
-
strain 6346/C, exoenzyme
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
6.5
-
-
6.5
-
substrate phenoxymethylpenicillin
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
4 - 9
-
substrate phenoxymethylpenicillin: kcat 1/6 at pH 9 compared to pH 6.5
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
50 - 75
-
pH 7: stable up to 58, 62, 68°C for K234E, wild type and K234A respectively
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
Uniprot
brenda
class A enzyme BS3
Uniprot
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
-
-
brenda
-
-
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
BLAC_BACLI
307
0
33996
Swiss-Prot
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
28500
-
calcultaed from amino acid composition
33000
-
cell-bound enzyme, PAGE, gel filtration
29000
-
electron spray mass spectrometry
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
purified recombinant enzyme, complexed with cefoxitin in an acyl-enzyme-adduct, for monoclinic crystals: 0.005 ml protein solution, 10 mg/ml, + equal volume of reservoir solution containing 25% PEG 6000, 0.1 M sodium acetate, pH 5.0, against 1 ml of reservoir solution at 20°C, for very big prismatic crystals: 40 mg/ml protein with lowered PEG 6000 concentration, pH 3.4, complexing by diffusion of cefoxitin for 24 h, X-ray diffraction structure determination and analysis at 1.7 A resolution
crystal structure of a BS3-lactivicin complex
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
E166C
mutant constructed to obtain an engineered beta-lactamase that contains an environment-sensitive fluorophore conjugated near its active site to probe the structural dynamics of the omega-loop and to detect the binding of substrates. Mutant enzyme carrying a 6-bromoacetyl-2-dimethylaminonaphthalene label shows improved binding kinetics and positive fluorescence signal toward oxyimino-cephalosporins, but shows little such effect to non-oxyimino-cephalosporins. The omega-loop adopts a less stabilized structure, and readily undergoes conformational change to accommodate the binding of bulky oxyimino-cephalosporins while no such change is observed for non-oxyimino-cephalosporins
K234A
-
no significant structural change, mutant with decreased Km 1-2 orders of magnitude and kcat 2-3 orders of magnitude
K234E
-
no significant structural change, mutant with decreased Km 1-2 orders of magnitude and kcat 2-3 orders of magnitude
ST70TS
-
mutant bacteria show no beta-lactamase activity
additional information
replacement, separately or simultaneously, three of the ESBL alpha helices with prototype amphiphatic helices from a catalog of secondary structure elements. Although the substitutes bear no sequence similarity to the originals and pertain to unrelated protein families, all the engineered ESBL variants fold in native like structures with in vitro and in vivo enzymic activity. The triple substituted variant resembles a primitive protein, with folding defects such as a strong tendency to oligomerization and very low stability. It mimics a non homologous recombinant abandoning the family sequence space while preserving fold
additional information
-
replacement, separately or simultaneously, three of the ESBL alpha helices with prototype amphiphatic helices from a catalog of secondary structure elements. Although the substitutes bear no sequence similarity to the originals and pertain to unrelated protein families, all the engineered ESBL variants fold in native like structures with in vitro and in vivo enzymic activity. The triple substituted variant resembles a primitive protein, with folding defects such as a strong tendency to oligomerization and very low stability. It mimics a non homologous recombinant abandoning the family sequence space while preserving fold
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
expression in Escherichia coli
expressed in Bacillus subtilis
-
expressed in Escherichia coli
-
expressed in Escherichia coli, Bacillus subtilis, Bacillus stearothermophilus
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Yamamoto, S.; Lampen, J.O.
Purification of plasma membrane penicillinase from Bacillus licheniformis 749/C and comparison with exoenzyme
J. Biol. Chem.
251
4095-4101
1976
Bacillus licheniformis, Bacillus licheniformis 749/C
brenda
Thatcher, D.R.
beta-Lactamase (Bacillus licheniformis)
Methods Enzymol.
43
652-664
1975
Bacillus licheniformis, Bacillus licheniformis 749/C, Bacillus licheniformis 6346/C
-
brenda
Citri, N.
Penicillinase and other beta-lactamases
The Enzymes, 3rd Ed. (Boyer, P. D. , ed. )
4
23-46
1971
Enterobacter cloacae, Bacillus cereus, Bacillus licheniformis, Escherichia coli, Staphylococcus aureus
-
brenda
Ledent, P.; Duez, C.; Vanhove, M.; Lejeune, A.; Fonze, E.; Charlier, P.; Rhazi-Filali, F.; Thamm, I.; Guillaume, G.; Samyn, B.; Devreese, B.; Van Beeumen, J.; Lamotte-Brasseur, J.; Frere, J.M.
Unexpected influence of a C-terminal His-tag on the processing of an enzyme and on the kinetic and folding parameters
FEBS Lett.
413
194-196
1997
Bacillus licheniformis, Bacillus licheniformis BS3
brenda
Wang, H.Y.; Zhang, M.; Imanaka, T.
Screening and separation of beta-lactam antibiotics using protein-engineered enzymes
Ann. N. Y. Acad. Sci.
613
376-384
1990
Bacillus licheniformis, Streptomyces sp.
brenda
Ellerby, L.M.; Escobar, W.A.; Fink, A.L.; Mitchinson, C.; Wells, J.A.
The role of lysine-234 in beta-lactamase catalysis probed by site directed mutagenesis
Biochemistry
29
5797-5806
1990
Bacillus licheniformis
brenda
Fonze, E.; Vanhove, M.; Dive, G.; Sauvage, E.; Frere, J.M.; Charlier, P.
Crystal structures of the Bacillus licheniformis BS3 class A beta-lactamase and of the acyl-enzyme adduct formed with cefoxitin
Biochemistry
41
1877-1885
2002
Bacillus licheniformis (P00808)
brenda
Brown, T.; Charlier, P.; Herman, R.; Schofield, C.J.; Sauvage, E.
Structural basis for the interaction of lactivicins with serine beta-lactamases
J. Med. Chem.
53
5890-5894
2010
Bacillus licheniformis (P94458)
brenda
Risso, V.A.; Primo, M.E.; Ermacora, M.R.
Re-engineering a beta-lactamase using prototype peptides from a library of local structural motifs
Protein Sci.
18
440-449
2009
Bacillus licheniformis (P00808), Bacillus licheniformis
brenda
Wong, W.T.; Chan, K.C.; So, P.K.; Yap, H.K.; Chung, W.H.; Leung, Y.C.; Wong, K.Y.; Zhao, Y.
Increased structural flexibility at the active site of a fluorophore-conjugated beta-lactamase distinctively impacts its binding toward diverse cephalosporin antibiotics
J. Biol. Chem.
286
31771-31780
2011
Bacillus licheniformis (P00808)
brenda
Transporter Classification Database (TCDB):
9.B.29.2.7